CN102596257B - 包含具有优良安全性概况的血浆阳离子的诊断组合物 - Google Patents

包含具有优良安全性概况的血浆阳离子的诊断组合物 Download PDF

Info

Publication number
CN102596257B
CN102596257B CN2010800498286A CN201080049828A CN102596257B CN 102596257 B CN102596257 B CN 102596257B CN 2010800498286 A CN2010800498286 A CN 2010800498286A CN 201080049828 A CN201080049828 A CN 201080049828A CN 102596257 B CN102596257 B CN 102596257B
Authority
CN
China
Prior art keywords
compound
diagnosis composition
calcium
ion concentration
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010800498286A
Other languages
English (en)
Chinese (zh)
Other versions
CN102596257A (zh
Inventor
L-G·维斯特兰
M·塔宁
B·牛顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare AS filed Critical GE Healthcare AS
Publication of CN102596257A publication Critical patent/CN102596257A/zh
Application granted granted Critical
Publication of CN102596257B publication Critical patent/CN102596257B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN2010800498286A 2009-10-29 2010-10-28 包含具有优良安全性概况的血浆阳离子的诊断组合物 Expired - Fee Related CN102596257B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09174413.6 2009-10-29
EP09174413 2009-10-29
PCT/EP2010/066351 WO2011051387A1 (en) 2009-10-29 2010-10-28 Diagnostic composition comprising plasma cations having superior safety profile

Publications (2)

Publication Number Publication Date
CN102596257A CN102596257A (zh) 2012-07-18
CN102596257B true CN102596257B (zh) 2013-08-21

Family

ID=43503035

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800498286A Expired - Fee Related CN102596257B (zh) 2009-10-29 2010-10-28 包含具有优良安全性概况的血浆阳离子的诊断组合物

Country Status (21)

Country Link
US (1) US8815210B2 (enExample)
EP (1) EP2493511B1 (enExample)
JP (1) JP5335147B2 (enExample)
KR (1) KR101545045B1 (enExample)
CN (1) CN102596257B (enExample)
AU (1) AU2010311478B2 (enExample)
BR (1) BR112012009859B1 (enExample)
CA (1) CA2773685C (enExample)
CO (1) CO6531477A2 (enExample)
DK (1) DK2493511T3 (enExample)
ES (1) ES2435299T3 (enExample)
HR (1) HRP20130991T1 (enExample)
IL (1) IL218456A (enExample)
IN (1) IN2012DN02126A (enExample)
MX (1) MX2012005021A (enExample)
NZ (1) NZ598540A (enExample)
PL (1) PL2493511T3 (enExample)
PT (1) PT2493511E (enExample)
RU (1) RU2544113C2 (enExample)
WO (1) WO2011051387A1 (enExample)
ZA (1) ZA201203505B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO333914B1 (no) * 2011-12-21 2013-10-21 Ge Healthcare As Stabilisering av diagnostisk røntgensammensetning
CA2862495A1 (en) 2012-01-11 2013-07-18 Ge Healthcare As X-ray imaging contrast media with low iodine concentration and x-ray imaging process
US20160279269A1 (en) * 2013-03-27 2016-09-29 Ge Healthcare As Method and reagent for preparing a diagnostic composition
US10575744B2 (en) 2017-02-24 2020-03-03 Medtronic Cryocath Lp Pericardial balloon mapping
CN109876157B (zh) * 2019-02-27 2020-12-15 浙江大学 离子特异性滤膜/介孔硅的复合材料、纳米传感器及其产品和应用
CN120114620B (zh) * 2025-03-18 2025-12-09 海南普利制药股份有限公司 一种碘帕醇注射液及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013636A1 (en) * 1990-03-09 1991-09-19 Cockbain, Julian, Roderick, Michaelson Contrast media
EP0390242B1 (en) * 1989-03-17 1995-06-21 Nycomed Imaging As Contrast media
WO2009008734A3 (en) * 2007-07-12 2009-10-29 Ge Healthcare As Contrast agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO161368C (no) * 1982-11-08 1989-08-09 Nyegaard & Co As Roentgenkontrastmidler samt radiologiske preparater derav.
DE4344464A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kaskadenpolymere mit Iodaromaten
GB9419203D0 (en) * 1994-09-23 1994-11-09 Nycomed Innovation Ab Contrast media
US8066970B2 (en) * 2006-05-11 2011-11-29 Ge Healthcare As Contrast agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0390242B1 (en) * 1989-03-17 1995-06-21 Nycomed Imaging As Contrast media
WO1991013636A1 (en) * 1990-03-09 1991-09-19 Cockbain, Julian, Roderick, Michaelson Contrast media
WO2009008734A3 (en) * 2007-07-12 2009-10-29 Ge Healthcare As Contrast agents

Also Published As

Publication number Publication date
ES2435299T3 (es) 2013-12-18
US20120328522A1 (en) 2012-12-27
EP2493511A1 (en) 2012-09-05
NZ598540A (en) 2014-03-28
IL218456A (en) 2015-08-31
CA2773685C (en) 2016-05-31
US8815210B2 (en) 2014-08-26
CN102596257A (zh) 2012-07-18
IN2012DN02126A (enExample) 2015-08-21
PT2493511E (pt) 2013-11-18
AU2010311478A1 (en) 2012-03-29
RU2012116882A (ru) 2013-12-10
JP2013509378A (ja) 2013-03-14
BR112012009859A2 (pt) 2016-08-30
HRP20130991T1 (hr) 2013-12-20
BR112012009859B1 (pt) 2019-10-22
KR101545045B1 (ko) 2015-08-17
RU2544113C2 (ru) 2015-03-10
AU2010311478B2 (en) 2015-09-24
PL2493511T3 (pl) 2014-05-30
CA2773685A1 (en) 2011-05-05
DK2493511T3 (da) 2013-11-25
MX2012005021A (es) 2012-06-19
CO6531477A2 (es) 2012-09-28
WO2011051387A1 (en) 2011-05-05
ZA201203505B (en) 2013-01-31
EP2493511B1 (en) 2013-10-16
IL218456A0 (en) 2012-04-30
KR20120091149A (ko) 2012-08-17
JP5335147B2 (ja) 2013-11-06

Similar Documents

Publication Publication Date Title
Geenen et al. Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
CN102596257B (zh) 包含具有优良安全性概况的血浆阳离子的诊断组合物
Berg Nephrotoxicity related to contrast media
Heyman et al. Acute renal failure with selective medullary injury in the rat.
Miao et al. Delivery of xenon-containing echogenic liposomes inhibits early brain injury following subarachnoid hemorrhage
JP3215703B2 (ja) 造影剤
KR20140109420A (ko) 저농도의 요오드를 포함하는 ｘ선 영상화 조영 매질 및 ｘ선 영상화 방법
US20170312309A1 (en) Intradialytic administration of sodium thiosulfate
JP2977045B2 (ja) 造影剤
JP2023543133A (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
Stratta et al. Structure-function relationships of iodinated contrast media and risk of nephrotoxicity
Erol et al. Chemistry, physicochemical properties and pharmacokinetics of iodinated contrast agents
Elmståhl et al. Histomorphological changes after renal X-ray arteriography using iodine and gadolinium contrast media in an ischemic porcine model
Elmståhl Are gadolinium contrast media really less nephrotoxic than iodine agents in radiographic examinations? A comparison in relation to their ability to attenuate x-rays in a pig model
Latif et al. Nephrotoxicity Related to Iodinated-Based Contrast Media: From Pathophysiology to Management
Chai et al. Adding sodium and calcium ions to the contrast medium iodixanol reduced the risk of ventricular fibrillation during perfusion of the left coronary artery in pigs: Effects of electrolytes, viscosity, and chemotoxicity of an isotonic perfusate1
LT3620B (en) Contrast media
JP2023543132A (ja) シクロデキストリンによるコレステロール結晶塞栓症の予防方法
Golman et al. Radiographic contrast media

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130821

Termination date: 20201028